This report marks the midway point of the 1/4/6×24 Campaign, which calls for the universal implementation of the best available TB regimens — as little as one month or once weekly for TB prevention, four months for drug-susceptible TB, and six months for drug-resistant TB — by the end of 2024. The report takes stock of what 1/4/6×24 has accomplished so far since its founding in 2022, and analyzes remaining gaps to be filled to reach its ambitious goal by the end of this year — particularly pertaining to the “4” regimen, for which uptake has been sorely limited and which original modeling shows has the potential to reduce total treatment time by 6.3 million years through 2030. Read the report here.
top of page
Recent Posts
See AllThe results of the TB-CHAMP trial were recently published. They showed that prophylactic levofloxacin can significantly reduce the risk...
80
This month, the Indian Patent Office denied the last of the three Janssen patent extension applications for bedaquiline. While TB...
30
The Institute of Tropical Medicine has announced two initiatives to honor the legacy of Armand Van Deun: a new meeting room in his name...
450
bottom of page
Comments